Clinical trial confirms the safety, efficacy of shortened radiation therapy for high-risk prostate cancer patients

A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy.

Related Keywords

Montreal ,Quebec ,Canada ,Canadian ,Tamimm Niazi ,Emily Henderson ,American Society For Radiation Oncology ,Lab Diagnostics Automation ,Mcgill University ,Lab Diagnostics Automation Industry ,Prostate Cancer Study ,American Society ,Radiation Oncology ,Lead Author ,Assistant Professor ,Radiation Oncologist ,Jewish General Hospital ,Automation Industry Focus ,Cancer ,Prostate ,Prostate Cancer ,Radiation Therapy ,Clinical Trial ,Efficacy ,Hospital ,Metastasis ,Ncology ,